The Group currently licenses its products, technologies and know-how to partner companies. The Group believes it can play an important role in improving access to healthcare through the development of innovative technologies and solutions that address major areas of unmet medical need, improve patient compliance and outcomes and reduce overall costs of healthcare. The Group utilises its development and regulatory expertise to support its partners in bringing the benefits of its products to as many markets as possible, including developing economies.
Although our business does not include direct marketing and sales to patients, patient safety is our number one priority in the development, testing, manufacturing and ultimate use of our products. All medicines have potential risks as well as benefits. Our robust policies and governance framework are designed to help us and our partners detect and act on any side effects that may be associated with our medicines. We always put patient safety first in the design and conduct of our clinical trials.